Search Results - "Barnes, Christopher O."
-
1
Evolution of antibody immunity to SARS-CoV-2
Published in Nature (London) (25-03-2021)“…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected 78 million individuals and is responsible for over 1.7 million deaths to date…”
Get full text
Journal Article -
2
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Published in Nature (London) (22-04-2021)“…Here we report on the antibody and memory B cell responses of a cohort of 20 volunteers who received the Moderna (mRNA-1273) or Pfizer–BioNTech (BNT162b2)…”
Get full text
Journal Article -
3
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
Published in Nature (London) (24-12-2020)“…The coronavirus disease 2019 (COVID-19) pandemic presents an urgent health crisis. Human neutralizing antibodies that target the host ACE2 receptor-binding…”
Get full text
Journal Article -
4
Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
Published in Nature (London) (15-07-2021)“…More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)…”
Get full text
Journal Article -
5
Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice
Published in Science (American Association for the Advancement of Science) (12-02-2021)“…Protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and SARS-related emergent zoonotic coronaviruses is urgently needed. We made…”
Get full text
Journal Article -
6
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies
Published in Cell (20-08-2020)“…Neutralizing antibody responses to coronaviruses mainly target the receptor-binding domain (RBD) of the trimeric spike. Here, we characterized polyclonal…”
Get full text
Journal Article -
7
Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
Published in Nature communications (07-07-2021)“…Monoclonal antibodies targeting a variety of epitopes have been isolated from individuals previously infected with SARS-CoV-2, but the relative contributions…”
Get full text
Journal Article -
8
Affinity maturation of SARS-CoV-2 neutralizing antibodies confers potency, breadth, and resilience to viral escape mutations
Published in Immunity (Cambridge, Mass.) (10-08-2021)“…Antibodies elicited by infection accumulate somatic mutations in germinal centers that can increase affinity for cognate antigens. We analyzed 6 independent…”
Get full text
Journal Article -
9
Partially Open HIV-1 Envelope Structures Exhibit Conformational Changes Relevant for Coreceptor Binding and Fusion
Published in Cell host & microbe (10-10-2018)“…HIV-1 Env, a trimer of gp120-gp41 heterodimers, mediates membrane fusion after binding host receptor CD4. Receptor binding displaces V1V2 loops from Env's…”
Get full text
Journal Article -
10
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Published in Science (American Association for the Advancement of Science) (04-12-2020)“…We developed a de novo protein design strategy to swiftly engineer decoys for neutralizing pathogens that exploit extracellular host proteins to infect the…”
Get full text
Journal Article -
11
Immunization expands B cells specific to HIV-1 V3 glycan in mice and macaques
Published in Nature (London) (01-06-2019)“…Broadly neutralizing monoclonal antibodies protect against infection with HIV-1 in animal models, suggesting that a vaccine that elicits these antibodies would…”
Get full text
Journal Article -
12
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
Published in Cell (06-02-2020)“…Broadly neutralizing antibodies (bNAbs) represent a promising approach to prevent and treat HIV-1 infection. However, viral escape through mutation of the…”
Get full text
Journal Article -
13
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Published in Cell (10-06-2021)“…Monoclonal antibodies (mAbs) are a focus in vaccine and therapeutic design to counteract severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its…”
Get full text
Journal Article -
14
The DDB1–DCAF1–Vpr–UNG2 crystal structure reveals how HIV-1 Vpr steers human UNG2 toward destruction
Published in Nature structural & molecular biology (01-10-2016)“…The crystal structure of HIV-1 accessory protein Vpr in complex with human UNG2 and DDB1–DCAF1 provides insight into how the viral protein directs UNG2 for…”
Get full text
Journal Article -
15
Crystal Structure of a Transcribing RNA Polymerase II Complex Reveals a Complete Transcription Bubble
Published in Molecular cell (16-07-2015)“…Notwithstanding numerous published structures of RNA Polymerase II (Pol II), structural details of Pol II engaging a complete nucleic acid scaffold have been…”
Get full text
Journal Article -
16
Detection and characterization of the SARS-CoV-2 lineage B.1.526 in New York
Published in Nature communications (09-08-2021)“…Wide-scale SARS-CoV-2 genome sequencing is critical to tracking viral evolution during the ongoing pandemic. We develop the software tool, Variant Database…”
Get full text
Journal Article -
17
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope
Published in Immunity (Cambridge, Mass.) (18-06-2019)“…Broadly neutralizing antibodies (bNAbs) against HIV-1 envelope (Env) inform vaccine design and are potential therapeutic agents. We identified SF12 and related…”
Get full text
Journal Article -
18
Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
Published in Cell reports (Cambridge) (28-09-2021)“…Many anti-severe acute respiratory syndrome coronavirus 2 (anti-SARS-CoV-2) neutralizing antibodies target the angiotensin-converting enzyme 2 (ACE2) binding…”
Get full text
Journal Article -
19
Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope
Published in Nature communications (28-03-2018)“…Broadly neutralizing antibodies (bNAbs) isolated from HIV-1-infected individuals inform HIV-1 vaccine design efforts. Developing bNAbs with increased efficacy…”
Get full text
Journal Article -
20
Cryo-EM structures of HIV-1 trimer bound to CD4-mimetics BNM-III-170 and M48U1 adopt a CD4-bound open conformation
Published in Nature communications (29-03-2021)“…Human immunodeficiency virus-1 (HIV-1), the causative agent of AIDS, impacts millions of people. Entry into target cells is mediated by the HIV-1 envelope…”
Get full text
Journal Article